Janece M Lovchik

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.

K. Subbarao, N. Hynes, K. Pierce, 2016, The Journal of infectious diseases.

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults.

K. Subbarao, N. Hynes, K. Pierce, 2015, The Journal of infectious diseases.

A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4&Dgr;30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers

A. Pletnev, K. Pierce, A. Durbin, 2017, The Journal of infectious diseases.

Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic.

B. Murphy, A. Durbin, A. Schmidt, 2011, The Journal of infectious diseases.

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination

K. Subbarao, N. Hynes, K. Pierce, 2017, PLoS neglected tropical diseases.

Polymerase chain reaction-based detection of B-cell clonality in the fine needle aspiration biopsy of a thyroid mucosa-associated lymphoid tissue (MALT) lymphoma.

D. Clark, J. Lovchik, M. Lane, 1997, Human pathology.